BioCentury
ARTICLE | Clinical News

Abbott Prism HIV O Plus assay regulatory update

September 28, 2009 7:00 AM UTC

FDA approved a BLA from Abbott for its Abbott Prism HIV O Plus assay as a screening tool to detect antibodies to HIV-1 group M and O subtypes and HIV-2 and to aid in the diagnosis of HIV-1 and HIV-2 i...